| 1 | The Authors Respond | 1ᵉʳ autor: Ortiz-Brizuela E., Schnitzer M.E., Carabali M., Talbot D. | 2025 | Epidemiology | Scopus-id: 2-s2.0-85217517643
| 0 | 0 |
| 2 | Potential biases in test-negative design studies of COVID-19 vaccine effectiveness arising from the inclusion of asymptomatic individuals | 1ᵉʳ autor: Ortiz-Brizuela E., Carabali M., Jiang C., Merckx J., et al. | 2025 | AMERICAN JOURNAL OF EPIDEMIOLOGY | Scopus-id: 2-s2.0-86000671412
| 0 | 2 |
| 3 | Global burden of bacterial antimicrobial resistance 1990?2021: a systematic analysis with forecasts to 2050 | Coautor: Ortiz-Brizuela E., Naghavi M., Vollset S.E., Ikuta K.S., et al. | 2024 | Lancet | WoS-id: 001381350300001
Scopus-id: 2-s2.0-85204727310
| 363 | 437 |
| 4 | Bias-interpretability Trade-offs in Vaccine Effectiveness Studies Using Test-negative or Cohort Designs | 2ᵒ autor: Ortiz-Brizuela E., Schnitzer M.E., Carabali M., Talbot D. | 2024 | Epidemiology | Scopus-id: 2-s2.0-85183722596
| 0 | 3 |
| 5 | The burden of antimicrobial resistance in the Americas in 2019: a cross-country systematic analysis | Coautor: Ortiz-Brizuela, E, Aguilar, GR, Swetschinski, LR, Weaver, ND, et al. | 2023 | LANCET REGIONAL HEALTH-AMERICAS | WoS-id: 001094633400001
Scopus-id: 2-s2.0-85170032148
| 59 | 76 |
| 6 | Increment Antimicrobial Resistance during the COVID-19 Pandemic: Results from the Invifar Network | Coautor: Ortiz-Brizuela E., López-Jácome L.E., Fernández-Rodríguez D., Franco-Cendejas R., et al. | 2022 | MICROBIAL DRUG RESISTANCE | WoS-id: 000729414600001
Scopus-id: 2-s2.0-85125883160
| 44 | 48 |
| 7 | Outcomes of patients with severe and critical COVID-19 treated with dexamethasone: a prospective cohort study | Coautor: Ortiz-Brizuela E., Martinez-Guerra B.A., Gonzalez-Lara M.F., Roman-Montes C.M., et al. | 2022 | EMERGING MICROBES & INFECTIONS | WoS-id: 000732459300001
Scopus-id: 2-s2.0-85121549711
| 15 | 16 |
| 8 | Effect of Tocilizumab in Mortality among Patients with Severe and Critical Covid-19: Experience in a Third-Level Medical Center | Coautor: Ortiz-Brizuela E., Martínez-Guerra B.A., de-León-Cividanes N.A., Tamez-Torres K.M., et al. | 2022 | REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION | WoS-id: 000753074100001
Scopus-id: 2-s2.0-85124435809
| 6 | 3 |
| 9 | NAFLD determined by Dallas Steatosis Index is associated with poor outcomes in COVID-19 pneumonia: a cohort study | Coautor: Ortiz-Brizuela E., Moctezuma-Velázquez P., Miranda-Zazueta G., Garay-Mora J.A., et al. | 2022 | INTERN EMERG MED | WoS-id: 000753233000001
Scopus-id: 2-s2.0-85124551300
| 14 | 14 |
| 10 | Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis | Coautor: Ortiz-Brizuela E., Murray C.J., Ikuta K.S., Sharara F., et al. | 2022 | Lancet | WoS-id: 000754571600022
Scopus-id: 2-s2.0-85124016440
| 7526 | 8626 |
| 11 | Large scale screening for SARS-CoV-2 among healthcare workers: Prevalence and risk factors for asymptomatic/pauci-symptomatic carriers, with emphasis on PPE use | Coautor: Ortiz-Brizuela E., Rajme-Lopez S., Gonzalez-Lara M.F., Roman-Montes C.M., et al. | 2022 | INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY | WoS-id: 000767342800001
Scopus-id: 2-s2.0-85101552380
| 4 | 1 |
| 12 | Risk Factors Associated with Failure of Linezolid Therapy in Vancomycin-Resistant Enterococcus faecium Bacteremia: A Retrospective Cohort Study in a Referral Center in Mexico | Coautor: Ortiz-Brizuela E., Lopez-Luis B.A., Ponce-De-León A., Lambraño-Castillo D., et al. | 2022 | MICROBIAL DRUG RESISTANCE | WoS-id: 000784441200001
Scopus-id: 2-s2.0-85131903221
| 5 | 5 |
| 13 | Erratum: In-hospital mortality from severe COVID-19 in a tertiary care center in Mexico City; causes of death, risk factors and the impact of hospital saturation (PLoS ONE 16(2) (e0245772) DOI: 10.1371/journal.pone.0245772) | Coautor: Ortiz-Brizuela E., Olivas-Martínez A., Cárdenas-Fragoso J.L., Jiménez J.V., et al. | 2022 | PLOS ONE | WoS-id: 001044877900006
Scopus-id: 2-s2.0-85130431737
| 0 | 1 |
| 14 | Testing and Treating Mycobacterium tuberculosis Infection | 1ᵉʳ autor: Ortiz-Brizuela E., Menzies D., Behr M.A. | 2022 | MED CLIN N AM | Scopus-id: 2-s2.0-85140287204
| 0 | 7 |
| 15 | In-hospital mortality from severe COVID-19 in a tertiary care center in Mexico City; causes of death, risk factors and the impact of hospital saturation | Coautor: Ortiz-Brizuela E., Olivas-Martínez A., Cárdenas-Fragoso J.L., Jiménez J.V., et al. | 2021 | PLOS ONE | WoS-id: 000616739700022
Scopus-id: 2-s2.0-85100668173
| 90 | 91 |
| 16 | Impact of undiagnosed type 2 diabetes and pre-diabetes on severity and mortality for SARS-CoV-2 infection | Coautor: Ortiz-Brizuela, Edgar, Vargas-Vazquez, Arsenio, Bello-Chavolla, Omar Yaxmehen, Campos-Munoz, Alejandro, et al. | 2021 | BMJ OPEN DIABETES RESEARCH & CARE | WoS-id: 000621085300003
Scopus-id: 2-s2.0-85100947709
| 40 | 49 |
| 17 | Antimicrobial resistance patterns and antibiotic use during hospital conversion in the COVID-19 pandemic | Coautor: Ortiz-Brizuela E., Martinez-Guerra B.A., Gonzalez-Lara M.F., de-Leon-Cividanes N.A., et al. | 2021 | ANTIBIOTICS-BASEL | WoS-id: 000622054300001
Scopus-id: 2-s2.0-85101512031
| 34 | 36 |
| 18 | Risk factors and outcomes associated with vancomycin-resistant Enterococcus faecium and ampicillin-resistant Enterococcus faecalis bacteraemia: A 10-year study in a tertiary-care centre in Mexico City | Coautor: Ortiz-Brizuela E., López-Luis B.A., Sifuentes-Osornio J., Lambraño-Castillo D., et al. | 2021 | JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE | WoS-id: 000634507300036
Scopus-id: 2-s2.0-85099839375
| 24 | 25 |
| 19 | Adverse Effects Associated With the Use of Antimalarials During The COVID-19 Pandemic in a Tertiary Care Center in Mexico City | Coautor: Ortiz-Brizuela E., Lozano-Cruz O.A., Jiménez J.V., Olivas-Martinez A., et al. | 2021 | FRONTIERS IN PHARMACOLOGY | WoS-id: 000662241400001
Scopus-id: 2-s2.0-85108205902
| 2 | 3 |
| 20 | Adaptive Metabolic and Inflammatory Responses Identified Using Accelerated Aging Metrics Are Linked to Adverse Outcomes in Severe SARS-CoV-2 Infection | Coautor: Ortiz-Brizuela, Edgar, Marquez-Salinas, Alejandro, Fermin-Martinez, Carlos A., Antonio-Villa N.E., et al. | 2021 | JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES | WoS-id: 000697988000005
Scopus-id: 2-s2.0-85105219727
| 11 | 12 |
| 21 | Prognostic factors in cancer patients infected with SARS-CoV-2: a Latin American country results | Coautor: Ortiz Brizuela, Edgar, Ruiz-Garcia, Erika, Pena-Nieves, Adriana, Alegria-Banos, Jorge, et al. | 2021 | THERAPEUTIC ADVANCES IN CHRONIC DISEASE | WoS-id: 000703270600001
Scopus-id: 2-s2.0-85116007085
| 7 | 7 |
| 22 | Point prevalence survey of antimicrobial use in four tertiary care hospitals in mexico | Coautor: Ortiz-Brizuela E., Zumaya-Estrada F.A., Ponce-De-león-garduño A., Tinoco-Favila J.C., et al. | 2021 | Infection and Drug Resistance | WoS-id: 000716422500003
Scopus-id: 2-s2.0-85121045361
| 6 | 6 |
| 23 | Tuberculosis preventive therapy for people living with HIV: A systematic review and network meta-analysis | 2ᵒ autor: Ortiz-Brizuela E., Yanes-Lane M., Campbell J.R., Benedetti A., et al. | 2021 | PLOS MEDICINE | WoS-id: 000724338300009
Scopus-id: 2-s2.0-85114941105
| 29 | 28 |
| 24 | An overlooked etiology of chronic diarrhea and wasting | 2ᵒ autor: Ortiz-Brizuela E., Ramos L.B., Darwin L.-C., Leon A.P.D. | 2021 | ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA | Scopus-id: 2-s2.0-85093656488
| 0 | 0 |
| 25 | Tuberculosis active case-finding: looking for cases in all the right places? | 1ᵉʳ autor: Ortiz-Brizuela E., Menzies D. | 2021 | LANCET PUBLIC HEALTH | Scopus-id: 2-s2.0-85103961653
| 0 | 9 |
| 26 | Low Thoracic Skeletal Muscle Area Is Not Associated With Negative Outcomes in Patients With COVID-19 | Coautor: Ortiz-Brizuela E., Moctezuma-Velázquez P., Miranda-Zazueta G., González-Lara M.F., et al. | 2021 | AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION | Scopus-id: 2-s2.0-85103993984
| 0 | 33 |
| 27 | The Evolution of Antimicrobial Resistance in Mexico during the Last Decade: Results from the INVIFAR Group | Coautor: Ortíz-Brizuela E., Garza-González E., Franco-Cendejas R., Morfín-Otero R., et al. | 2020 | MICROBIAL DRUG RESISTANCE | WoS-id: 000512588100001
Scopus-id: 2-s2.0-85095461069
| 22 | 24 |
| 28 | The influence of hospital antimicrobial use on carbapenem-non-susceptible Enterobacterales incidence rates according to their mechanism of resistance: a time-series analysis | 1ᵉʳ autor: Ortiz-Brizuela E., Caro-Vega Y., Bobadilla-del-Valle M., Leal-Vega F., et al. | 2020 | JOURNAL OF HOSPITAL INFECTION | WoS-id: 000558706900033
Scopus-id: 2-s2.0-85088372702
| 5 | 3 |
| 29 | Osborn J-Wave in a Patient with Hypercalcemic Crisis | Coautor: Ortiz-Brizuela E., Manzur-Sandoval D., Dueñas-Pérez G., Valdez-Hernández P., et al. | 2020 | J EMERG MED | WoS-id: 000572677200029
Scopus-id: 2-s2.0-85084985069
| 2 | 3 |
| 30 | Validation and repurposing of the MSLCOVID- 19 score for prediction of severe COVID-19 using simple clinical predictors in a triage setting: The Nutri-CoV score | Coautor: Ortiz-Brizuela E., Bello-Chavolla O.Y., Antonio-Villa N.E., Vargas-Vázquez A., et al. | 2020 | PLOS ONE | WoS-id: 000600176400011
Scopus-id: 2-s2.0-85098289191
| 24 | 21 |
| 31 | CLINICAL AND EPIDEMIOLOGICAL CHARACTERISTICS OF PATIENTS DIAGNOSED WITH COVID-19 IN A TERTIARY CARE CENTER IN MEXICO CITY: A PROSPECTIVE COHORT STUDY | 1ᵉʳ autor: Ortiz-Brizuela E., Villanueva-Reza M., González-Lara M.F., Tamez-Torres K.M., et al. | 2020 | REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION | WoS-id: 000613899200008
Scopus-id: 2-s2.0-85087100323
| 95 | 77 |
| 32 | Erratum: CLINICAL AND EPIDEMIOLOGICAL CHARACTERISTICS OF PATIENTS DIAGNOSED WITH COVID-19 IN A TERTIARY CARE CENTER IN MEXICO CITY: A PROSPECTIVE COHORT STUDY (Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion (2020) 72 3 (165-177)) | 1ᵉʳ autor: Ortiz-Brizuela E., Villanueva-Reza M., González-Lara M.F., Tamez-Torres K.M., et al. | 2020 | REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION | WoS-id: 000613899300010
Scopus-id: 2-s2.0-85093705589
| 0 | 9 |
| 33 | Histoplasma panniculitis in a patient with systemic lupus erythematosus | 2ᵒ autor: Ortiz-Brizuela E., Flores-Bozo L.R., Soto-Ramírez L.E. | 2019 | ANAIS BRASILEIROS DE DERMATOLOGIA | WoS-id: 000457571600018
Scopus-id: 2-s2.0-85061142890
| 4 | 4 |
| 34 | Response to Dr Jolobe: 'Optimizing diagnostic strategies in emphysematous osteomyelitis' | Coautor y autor de correspondencia: Ortiz-Brizuela E., Lopez Luis B.A., Antiga-Lopez F.J. | 2019 | QJM-AN INTERNATIONAL JOURNAL OF MEDICINE | WoS-id: 000462833300021
Scopus-id: 2-s2.0-85060828538
| 0 | 0 |
| 35 | False-positive results in the galactomannan Platelia? Aspergillus assay with generic piperacillin/tazobactam | 1ᵉʳ autor: Ortiz-Brizuela E., Rangel-Cordero A., Ponce-de-León A., Sierra-Madero J. | 2019 | REVISTA IBEROAMERICANA DE MICOLOGIA | WoS-id: 000462948200011
Scopus-id: 2-s2.0-85062666930
| 6 | 7 |
| 36 | Vaccine-derived varicella zoster infection in a kidney transplant recipient after zoster vaccine live administration | 1ᵉʳ autor: Ortiz-Brizuela E., Leal-Vega F., Cuellar-Rodríguez J., Bobadilla-del-Valle M., et al. | 2019 | Vaccine | WoS-id: 000474325600009
Scopus-id: 2-s2.0-85065773613
| 10 | 11 |
| 37 | Acute appendicitis after kidney transplantation: Experience at a tertiary care hospital in Mexico city | 1ᵉʳ autor: Ortiz-Brizuela E., Quiroz-Compeán A., Vilatobá-Chapa M., Alberú-Gómez J. | 2018 | EXP CLIN TRANSPLANT | WoS-id: 000433396600007
Scopus-id: 2-s2.0-85045117478
| 3 | 3 |
| 38 | A patient with neutropenic fever and intraosseous gas | Coautor y autor de correspondencia: Ortiz-Brizuela E., Lopez Luis B.A., Antiga-López F.J. | 2018 | QJM-AN INTERNATIONAL JOURNAL OF MEDICINE | WoS-id: 000446090500021
Scopus-id: 2-s2.0-85054155976
| 2 | 2 |
| 39 | Chronic pulmonary aspergillosis after pulmonary tuberculosis | 1ᵉʳ autor: Ortiz-Brizuela E., Ponce-De-León A. | 2018 | CAN MED ASSOC J | WoS-id: 000448604600005
Scopus-id: 2-s2.0-85054060550
| 1 | 1 |
| 40 | Acute Cholangitis After Bilioenteric Anastomosis for Bile Duct Injuries | 1ᵉʳ autor: Ortiz-Brizuela E., Sifuentes-Osornio J., Manzur-Sandoval D., Terán-Ellis S.M.Y., et al. | 2017 | JOURNAL OF GASTROINTESTINAL SURGERY | WoS-id: 000413667600008
Scopus-id: 2-s2.0-85025832937
| 3 | 7 |
| 41 | Associated factors and outcomes for OXA-232 Carbapenem-resistant Enterobacteriaceae infections in a tertiary care centre in Mexico City: A case?control-control study | 2ᵒ autor: Ortiz-Brizuela E., Torres-González P., Cervera-Hernandez M.E., Bobadilla-del Valle M., et al. | 2016 | DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE | WoS-id: 000384395400024
Scopus-id: 2-s2.0-84989895591
| 8 | 8 |
| 42 | Lactic Acidosis Complicating Metformin and Non-Nucleoside Reverse Transcriptase Inhibitor Combination Therapy: A Smoldering Threat in the Post-HAART Era | 1ᵉʳ autor: Ortiz-Brizuela E., Pérez-Patrigeon S., Recillas-Gispert C., Gómez-Pérez F.J. | 2015 | REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION | WoS-id: 000368650700009
Scopus-id: 2-s2.0-85035101176
| 7 | 5 |
ID's SCOPUS 
ORCID's 